Literature DB >> 17664449

Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities.

Liviana Calzavara1, Nancy Ramuscak, Ann N Burchell, Carol Swantee, Ted Myers, Peter Ford, Margaret Fearon, Sue Raymond.   

Abstract

BACKGROUND: Each year more than 56 000 adult and young offenders are admitted to Ontario's remand facilities (jails, detention centres and youth centres). The prevalence of HIV infection in Ontario remand facilities was last measured over a decade ago, and no research on the prevalence of hepatitis C virus (HCV) infection has been conducted in such facilities. We sought to determine the prevalence of HIV infection, HCV infection and HIV-HCV coinfection among inmates in Ontario's remand facilities.
METHODS: A voluntary and anonymous cross-sectional prevalence study of HIV and HCV infections was conducted among people admitted to 13 selected remand facilities across Ontario between Feb. 1, 2003, and June 20, 2004. Data collection included a saliva specimen for HIV and HCV antibody screening and an interviewer-administered survey. Prevalence rates and 95% confidence intervals were calculated and examined according to demographic characteristics, region of incarceration and self-reported history of injection drug use.
RESULTS: In total, 1877 participants provided both a saliva specimen and survey information. Among the adult participants, the prevalence of HIV infection was 2.1% among men and 1.8% among women. Adult offenders most likely to have HIV infection were older offenders (> or = 30 years) and injection drug users. The prevalence of HCV infection was 15.9% among men, 30.2% among women and 54.7% among injection drug users. Adult offenders most likely to have HCV infection were women, older offenders (> or = 30 years) and injection drug users. The prevalence of HCV-HIV coinfection was 1.2% among men and 1.5% among women. It was highest among older inmates and injection drug users. Among the young offenders, none was HIV positive and 1 (0.4%) was HCV positive. On the basis of the study results, we estimated that 1079 HIV-positive adults and 9208 HCV-positive adults were admitted to remand facilities in Ontario from Apr. 1, 2003, to Mar. 31, 2004.
INTERPRETATION: Adult offenders entering Ontario remand facilities have a considerably higher prevalence of HIV and HCV infections than the general population.

Entities:  

Mesh:

Year:  2007        PMID: 17664449      PMCID: PMC1930192          DOI: 10.1503/cmaj.060416

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

1.  HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group.

Authors:  P M Ford; M Pearson; P Sankar-Mistry; T Stevenson; D Bell; J Austin
Journal:  QJM       Date:  2000-02

2.  HIV-1 infection in a medium security prison for women--Quebec.

Authors:  C Hankins; S Gendron; C Richard; M O'Shaughnessy
Journal:  Can Dis Wkly Rep       Date:  1989-08-19

3.  The prevalence of HIV-1 infection among inmates in Ontario, Canada.

Authors:  L M Calzavara; C Major; T Myers; J Schlossberg; M Millson; E Wallace; J Rankin; M Fearon
Journal:  Can J Public Health       Date:  1995 Sep-Oct

4.  Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV RNA in serum.

Authors:  G J van Doornum; A Lodder; M Buimer; E J van Ameijden; S Bruisten
Journal:  J Med Virol       Date:  2001-05       Impact factor: 2.327

5.  HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention.

Authors:  Prithwish De; Nancy Connor; Françoise Bouchard; Donald Sutherland
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

6.  Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City.

Authors:  A Dufour; M Alary; C Poulin; F Allard; L Noël; G Trottier; D Lépine; C Hankins
Journal:  AIDS       Date:  1996-08       Impact factor: 4.177

7.  Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.

Authors:  Jennifer A Gates; Jeffrey J Post; John M Kaldor; Yong Pan; Paul S Haber; Andrew R Lloyd; Kate A Dolan
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

8.  Prevalence of HIV infection in provincial prisons in British Columbia.

Authors:  D A Rothon; R G Mathias; M T Schechter
Journal:  CMAJ       Date:  1994-09-15       Impact factor: 8.262

9.  Prior opiate injection and incarceration history predict injection drug use among inmates.

Authors:  Liviana M Calzavara; Ann N Burchell; Julia Schlossberg; Ted Myers; Michael Escobar; Evelyn Wallace; Carol Major; Carol Strike; Margaret Millson
Journal:  Addiction       Date:  2003-09       Impact factor: 6.526

10.  HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology.

Authors:  C A Hankins; S Gendron; M A Handley; C Richard; M T Tung; M O'Shaughnessy
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

View more
  25 in total

1.  Practice spotlight: pharmacy practice in a correctional setting.

Authors: 
Journal:  Can J Hosp Pharm       Date:  2011-11

2.  Deadly disregard: government refusal to implement evidence-based measures to prevent HIV and hepatitis C virus infections in prisons.

Authors:  Richard Elliott
Journal:  CMAJ       Date:  2007-07-31       Impact factor: 8.262

3.  Expansion of CMAJ's support for health promotion and disease prevention.

Authors:  Noni MacDonald; Erica Weir; David Patrick; Louise Potvin; Jeff Scott
Journal:  CMAJ       Date:  2007-07-31       Impact factor: 8.262

Review 4.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

5.  [Not Available].

Authors:  Mark Hull; Pierre Giguère; Marina Klein; Stephen Shafran; Alice Tseng; Pierre Côté; Marc Poliquin; Curtis Cooper
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

Review 6.  Health status of prisoners in Canada: Narrative review.

Authors:  Fiona Kouyoumdjian; Andrée Schuler; Flora I Matheson; Stephen W Hwang
Journal:  Can Fam Physician       Date:  2016-03       Impact factor: 3.275

7.  HIV and Viral Hepatitis Among Imprisoned Key Populations.

Authors:  Andrea L Wirtz; Ping T Yeh; Natalie L Flath; Chris Beyrer; Kate Dolan
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

8.  Prevalence and predictors of urethral chlamydia and gonorrhea infection in male inmates in an Ontario correctional facility.

Authors:  Fiona G Kouyoumdjian; Cheryl Main; Liviana M Calzavara; Lori Kiefer
Journal:  Can J Public Health       Date:  2011 May-Jun

9.  CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.

Authors:  Mark Hull; Marina Klein; Stephen Shafran; Alice Tseng; Pierre Giguère; Pierre Côté; Marc Poliquin; Curtis Cooper
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

10.  Correlates of incarceration among young methamphetamine users in Chiang Mai, Thailand.

Authors:  Nicholas Thomson; Catherine G Sutcliffe; Bangorn Sirirojn; Rassamee Keawvichit; Kanlaya Wongworapat; Kamolrawee Sintupat; Apinun Aramrattana; David D Celentano
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.